
Join to view full profile
1824 6th Avenue SBirmingham, AL 35233
Phone+1 205-934-4011
Dr. Malla is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Midhun Malla, MD is an Oncologist based in Birmingham, Alabama with a focus in Medical Oncology. He completed his residency in Internal Medicine at Creighton University School of Medicine in 2016 and his fellowship at University of Oklahoma Health Sciences Center in 2019. Dr. Malla is also known for his wealth of publications, most notably "Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices", which has been published in Journal of Clinical Oncology and cited more than 250 times.
Education & Training
University of Oklahoma Health Sciences CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
Creighton University School of Medicine-PhoenixResidency, Internal Medicine, 2013 - 2016
Guntur Medical College NTRClass of 2011
Certifications & Licensure
OK State Medical License 2016 - 2027
WV State Medical License 2019 - 2027
AL State Medical License 2023 - 2026
IL State Medical License 2025 - 2026
IA State Medical License 2023 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Patient characteristics to guide personalized treatment decisions and prognostication in hepatocellular carcinoma.Aaqid Syed, Mehmet Akce, Midhun Malla
Hepatic Oncology. 2026-12-01 - 1 citationsIntegrated clinicogenomic analysis reveals the evolution and metastatic tropisms of advanced colorectal cancer.Paolo Manca, Henry Walch, Jierui Xu, Natalie Small, Ayush Kris
Cancer Cell. 2026-09-14 - Quantitative dynamic contrast-enhanced magnetic resonance imaging for early assessment of treatment response in pancreatic ductal adenocarcinoma.Martin D Holland, Ezinwanne E Onuoha, Darryl Outlaw, Mehmet Akce, Midhun Malla
European Radiology. 2026-08-22
Press Mentions
NCCN Clinical Practice Guidelines in Oncology: 2023 UpdatesMay 19th, 2023
New Doctors Join WVU Medicine in Morgantown, MartinsburgJuly 2nd, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: